mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.08 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.08 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.08 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.08 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.3 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |